When the teaser for Suryaa burst onto screens on October 19, the same day Sunny Deol celebrated his 69th birthday, the Indian Medical Association was already drafting a letter to Minister Ashwini Vaishnaw.
The IMA’s note, dated just days after the teaser hit social media, argues that the film’s portrayal of doctors as corrupt and prone to violence could paint an unfair, generalized picture of the entire profession. It cites scenes where a retired policeman‑turned‑hero—played by Deol—fights a system that, according to the letter, lets a handful of doctors profit at patients’ expense.
“We wish to express our serious concern regarding the portrayal of the medical profession in the film ‘Suryaa – Ant Se Aarambh Tak,’” the IMA writes, listing four main points: unfair generalisation, depiction of violence against medical staff, safety risks for healthcare workers, and undermining public confidence in the doctor‑patient relationship. The body’s language is calm but firm, framing the issue as one of public safety rather than mere censorship.
On the other side, the film’s producers—Deepak, Hemmant, and Lokesh Mukut—claim the story is a crime thriller adapted from the 2018 Malayalam hit Joseph. Director M Padmakumar says the narrative follows a retired cop uncovering a web of corruption that touches the medical field, but that the film’s intent is to expose systemic abuse, not to vilify doctors.
The debate has already spilled into the headlines: “Suryaa’s teaser shows Deol vowing justice for betrayed doctors,” a headline that caught the attention of both cinema buffs and professional bodies. The IMA’s letter, meanwhile, requests an impartial review and hints at potential corrective measures, even suggesting a ban if the film’s content is found to violate public interest.
What comes next? The Union Minister’s office has yet to issue a response, but industry insiders whisper that the film’s release date—scheduled for early next year—might face a short delay while the matter is investigated. For fans of Deol’s “angry man” persona, the controversy may add an extra layer of tension, turning a courtroom drama into a real‑world courtroom of public opinion.
Whether the government sides with the medical community or defends artistic freedom remains to be seen, but one thing is clear: Suryaa is already a conversation starter, and its final cut will likely be scrutinised as closely as its plot.